In addition, we have determined that the SRPK2-related pathway could be associated with the activation of microglial cells in AD pathology as well as the neuroprotective effects of SRPK2 inhibition in the Aβ-activated BV2 cells. The gene discussed is SRPK2; the disease is Alzheimer disease.